Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas

By Colao Annamaria   Filippella Mariagiovanna   Somma Carolina   Manzi Simona   Rota Francesca   Pivonello Rosario   Gaccione Maria   Rosa Michele   Lombardi Gaetano  

Endocrine Journal, Vol. 20, Iss. 3, 2003-04 ,pp. : 279-283

Humana Press, Inc

Access to resources Recommend Favorite

Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs

By Shimon Ilan  

Endocrine Journal, Vol. 20, Iss. 3, 2003-04 ,pp. : 265-269

Humana Press, Inc

Access to resources Recommend Favorite

Immunohistochemical detection of somatostatin receptor subtypes in “clinically nonfunctioning” pituitary adenomas

By Pawlikowski Marek   Pisarek Hanna   Kunert-Radek Jolanta   Radek Andrezej  

Endocrine Pathology, Vol. 14, Iss. 3, 2003-09 ,pp. : 231-238

Humana Press, Inc

Access to resources Recommend Favorite

Octreotide effect on growth hormone and somatostatin subtype 2 receptor mRNAs of the human pituitary somatotroph adenomas

By Stefaneanu Lucia   Kovacs Kalman   Thapar Kamal   Horvath Eva   Melmed Shlomo   Greenman Yona  

Endocrine Pathology, Vol. 11, Iss. 1, 2000-03 ,pp. : 41-48

Humana Press, Inc

Access to resources Recommend Favorite

Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland

By Deghenghi Romano   Papotti Mauro   Ghigo Ezio   Muccioli Giampiero   Locatelli Vittorio  

Endocrine Journal, Vol. 14, Iss. 1, 2001-02 ,pp. : 29-33

Humana Press, Inc

Access to resources Recommend Favorite